Literature DB >> 23887584

First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile.

Ricardo Marcos-Pinto1, Mário Dinis-Ribeiro, Fátima Carneiro, Xiaogang Wen, Carlos Lopes, Céu Figueiredo, José Carlos Machado, Rui M Ferreira, Celso A Reis, Paulo Canedo, Cecília Durães, José Ferreira, Isabel Pedroto, Jorge Areias.   

Abstract

First-degree relatives (FDR) of early-onset gastric cancer (EOGC) is presumed to be a population with a distinct molecular and phenotypic profile, regarding the prevalence of gastric premalignant conditions and the association with Helicobacter pylori infection and host proinflammatory gene polymorphisms. A case-control study was conducted with FDR of EOGC patients (n = 103) and age and gender matched controls (n = 101; ranging from spouses to neighbors and dyspeptics). Upper endoscopy was performed, Operative Link on Gastritis Assessment (OLGA) system used for staging and H. pylori (cagA and vacA) and host IL1B-511, IL1RN intron2 VNTR and IFNGR1-56 genotyping. Seventy percent of cases showed atrophy, while 19 % presented with high-stage gastritis (OLGA stage III or IV) (p < 0.001); gastric dysplasia was present in seven cases (vs none in controls) (p = 0.007). In cases, H. pylori was present in 82 % (vs 62 % in controls; p = 0.004) with vacA s1 and vacA m1 + strains significantly associated with the presence of atrophy; individuals homozygous for IL1B-511*T present a significantly higher risk for dysplasia. An increased global prevalence of IFNGR1-56*T/*T polymorphism (37 % in cases vs 24 % in controls; p = 0.03) was observed with no association with atrophic changes or dysplasia. All trends observed were kept when comparing FDR of EOGC with spouses, neighbors, or dyspeptic controls. We demonstrated that FDR of EOGC patients have an increased prevalence of high-risk OLGA stages and dysplasia that seem to be associated with high virulence H. pylori strains and pro-inflammatory host genotypes, including a possible population-specific risk marker. FDR of EOGC patients may merit specific management through endoscopic and histopathological adequate assessment of gastric mucosa and surveillance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887584     DOI: 10.1007/s00428-013-1458-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  53 in total

1.  Staging gastritis: an international proposal.

Authors:  Massimo Rugge; Robert M Genta
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

Review 2.  The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection.

Authors:  A C de Vries; J Haringsma; E J Kuipers
Journal:  Helicobacter       Date:  2007-02       Impact factor: 5.753

3.  Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study.

Authors:  M Rugge; M de Boni; G Pennelli; M de Bona; L Giacomelli; M Fassan; D Basso; M Plebani; D Y Graham
Journal:  Aliment Pharmacol Ther       Date:  2010-02-23       Impact factor: 8.171

4.  Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis.

Authors:  Theodore Rokkas; Panos Sechopoulos; Dimitrios Pistiolas; Georgios Margantinis; Georgios Koukoulis
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-09       Impact factor: 2.566

5.  Gastric carcinoma in young adults in Japan.

Authors:  K Umeyama; M Sowa; K Kamino; Y Kato; K Satake
Journal:  Anticancer Res       Date:  1982 Sep-Oct       Impact factor: 2.480

6.  IL-1B -31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers.

Authors:  R Sitarz; W W J de Leng; M Polak; F H M Morsink; O Bakker; W P Polkowski; R Maciejewski; G J A Offerhaus; A N Milne
Journal:  Virchows Arch       Date:  2008-08-08       Impact factor: 4.064

7.  Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection.

Authors:  Thorsten Thye; Gerd D Burchard; Manfred Nilius; Bertram Müller-Myhsok; Rolf D Horstmann
Journal:  Am J Hum Genet       Date:  2003-01-06       Impact factor: 11.025

8.  A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia.

Authors:  M Dinis-Ribeiro; C Lopes; A da Costa-Pereira; M Guilherme; J Barbosa; H Lomba-Viana; R Silva; L Moreira-Dias
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

Review 9.  Carcinogenesis of Helicobacter pylori.

Authors:  Pelayo Correa; Jeanmarie Houghton
Journal:  Gastroenterology       Date:  2007-08       Impact factor: 22.682

10.  Family history and the risk of gastric cancer.

Authors:  M Yaghoobi; R Bijarchi; S A Narod
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more
  5 in total

Review 1.  Evaluation and Management of Gastric Superficial Neoplastic Lesions.

Authors:  Pedro Pimentel-Nunes; Diogo Libânio; Mário Dinis-Ribeiro
Journal:  GE Port J Gastroenterol       Date:  2016-11-01

2.  From inflammation to gastric cancer: Role of Helicobacter pylori.

Authors:  Xiao-Ying Zhang; Pei-Ying Zhang; Mourad A M Aboul-Soud
Journal:  Oncol Lett       Date:  2016-12-15       Impact factor: 2.967

Review 3.  Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype.

Authors:  Małgorzata Pucułek; Julita Machlowska; Ryszard Wierzbicki; Jacek Baj; Ryszard Maciejewski; Robert Sitarz
Journal:  Oncotarget       Date:  2018-07-24

Review 4.  Helicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric Cancer.

Authors:  Jun-Bo Hong; Wei Zuo; An-Jiang Wang; Nong-Hua Lu
Journal:  Int J Med Sci       Date:  2016-04-08       Impact factor: 3.738

5.  Genetic Variations and Gastric Cancer Risk.

Authors:  Ricardo Marcos-Pinto
Journal:  GE Port J Gastroenterol       Date:  2015-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.